一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Drugs >>article
Drugs

Drugs

IF: 13
Download PDF

Fenofibrate and Dyslipidemia: Still a Place in Therapy?

Published:1 September 2018 DOI: 10.1007/s40265-018-0965-8 PMID: 30159817
Nicola Tarantino, Francesco Santoro, Michele Correale, Luisa De Gennaro, Silvio Romano, Matteo Di Biase, Natale Daniele Brunetti

Abstract

Dyslipidemia is one of the major cardiovascular risk factors, but beyond statin treatment-which represents the cornerstone of therapy-a relevant practical uncertainty regards the use of fibrate derivatives. In the lack of successful results from the main cardiovascular trials, guidelines recommend the use of peroxisome proliferator-activated receptor agonists in selected cases, i.e. patients with true atherogenic dyslipidemia. However, recent observations indicate that fenofibrate treatment may provide a reliable complementary support against residual cardiovascular risk. We therefore summarize current evidence on fenofibrate, seeking to provide an updated interpretation of recent studies in the field.

Substances (1)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Fenofibrate 49562-28-9 C20H21ClO4 784 suppliers $5.00-$602.00

Similar articles

IF:2.8

Gibberellic acid in plant: still a mystery unresolved.

Plant Signaling & Behavior Ramwant Gupta, S K Chakrabarty,etc Published: 1 September 2013
IF:13

Fenofibrate: a review of its use in dyslipidaemia.

Drugs Kate McKeage, Gillian M Keating,etc Published: 1 October 2011
IF:0

Place of alfacalcidol in treatment of osteoporosis and osteoporotic fractures

Medical alphabet N. Toroptsova,?O. Nikitinskaya,etc Published: 25 December 2022
乌鲁木齐市| 泰顺县| 芦溪县| 灵山县| 林芝县| 从江县| 即墨市| 榆社县| 南投县| 岗巴县| 石城县| 梅河口市| 西盟| 陕西省| 永川市| 年辖:市辖区| 田阳县| 青海省| 阳原县| 富阳市| 独山县| 张家川| 万安县| 巍山| 高雄市| 民权县| 泰安市| 肥乡县| 太原市| 勐海县| 永仁县| 临沂市| 汉沽区| 濮阳县| 肃南| 东平县| 玉田县| 福安市| 红桥区| 隆安县| 黄骅市|